# NIRS Ticagrelor Evaluation

> **NCT02282332** · PHASE4 · COMPLETED · sponsor: **Medstar Health Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02282332
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282332, "NIRS Ticagrelor Evaluation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02282332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*